Overview
Ruicheng Wu practices practicing medicine in Chengdu, China.
Their clinical expertise encompasses Bladder Cancer, Prostate Cancer, Non-Muscle Invasive Bladder Cancer, Urothelial Cancer, and Prostatectomy.
They are actively involved in clinical research, co-authoring 59 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ruicheng Wu
Is Ruicheng Wu a top-rated expert for Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Ruicheng Wu is classified as an Experienced expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ruicheng Wu participate in research or clinical trials?
Yes. Ruicheng Wu has published 59 articles and abstracts on conditions like Bladder Cancer. You can view a list of Ruicheng Wu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bladder CancerWu isExperienced. Learn about Bladder Cancer.
- Non-Muscle Invasive Bladder Cancer
- Prostate CancerWu isExperienced. Learn about Prostate Cancer.
- ProstatectomyWu isExperienced. Learn about Prostatectomy.
- Urothelial CancerWu isExperienced. Learn about Urothelial Cancer.